🌍·Jun 23Research
HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation.
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- June 23, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Universitätsspital Zürich (USZ)/1h ago
Regina Gerdes verlässt das Universitätsspital Zürich
UNMC/2h ago
UNMC to host America 250 event today
Policlinico di Milano/4h ago
#NUTRICETTE. Insalata estiva di ceci, cetriolo, avocado e menta
Hospital Clínic de Barcelona/4h ago